FDA-regulated operations
Process documentation, change control, and training records built to hold up under inspection. OEP structures the evidence trail as work is performed, so readiness becomes a review rather than a scramble before every audit.
Overview / Regulatory
Regulatory & compliance
OEP builds processes, documentation, and training for organizations operating under FDA oversight, ISO 13485 quality systems, CLIA, and GMP — where a process that is not documented is a process that did not happen.
The premise
Most organizations treat inspection readiness as an event: weeks of assembling evidence, reconstructing decisions, and locating the records that prove what happened. That effort is a symptom of documentation generated after the fact rather than during the work.
OEP designs operations so the evidence trail is a byproduct of doing the job correctly. Batch records, training files, change control, and quality data accumulate as work is performed, which turns preparation into a review rather than a scramble.
Regulatory & operating context
OEP works inside the frameworks that govern life sciences operations, and across both sides of the business — the commercial functions that ship product and the research functions that create it.
Process documentation, change control, and training records built to hold up under inspection. OEP structures the evidence trail as work is performed, so readiness becomes a review rather than a scramble before every audit.
Quality management system requirements for medical device organizations — document control, supplier qualification, traceability, and the operational discipline that keeps a QMS accurate between audits.
Laboratory operations under CLIA — personnel competency documentation, procedure manuals, quality control records, and proficiency requirements. For laboratories running LDTs, OEP builds the validation records, standard operating procedures, and change control that hold up regardless of how oversight requirements settle.
The functions that move product: demand planning, distribution, SKU and item master management, third-party logistics coordination, and the reporting that connects supply performance to revenue.
Research environments have operational needs too — reagent and consumable management, sample and specimen tracking, lab onboarding, and data capture that survives the transition from bench to production.
Laboratory and diagnostics work touches protected health information whether or not the engagement intends to. OEP scopes work to avoid PHI where possible, operates under your BAA and access controls where it cannot, and designs data collection so specimen and result records stay separated from the operational metrics that drive decisions.
What OEP delivers
Deliverables are built to be used daily and to survive examination, rather than written for the binder.
Standard operating procedures written from observed practice rather than from an ideal that nobody follows. Version controlled, reviewed on a schedule, and written at the reading level of the person performing the task.
Competency verification that measures demonstrated skill rather than attendance, with records structured to satisfy CLIA personnel requirements and quality system training obligations.
A change process people can actually follow, with defined authority, documented rationale, and impact assessment — so that changes are captured rather than made informally and discovered later.
Lot and batch traceability that runs both directions, expiry rotation that is enforced rather than intended, and recall procedures that have been tested rather than only written.
Qualification criteria, approved supplier lists, and incoming inspection tied to actual risk, with the documentation trail that supports each decision.
Operational reporting designed so regulated content stays separated from the metrics that circulate for decision-making, with access controls and minimum-necessary handling where PHI is unavoidable.
Common situations
An audit or inspection surfaced a documentation or training gap, and the corrective action needs to be real rather than a memo.
A growing organization approaching its first serious regulatory examination, with processes that worked at ten people and will not work at forty.
Moving a process from research into production, adding a site, or bringing a new test or product line into an existing quality system.
Describe what is happening and OEP will give you a straight assessment of whether this is work we can help with.